The European Society for Therapeutic Radiology and Oncology (ESTRO), the European Head and Neck Society (EHNS), and the European Society for Medical Oncology (ESMO) in collaboration with other European partners, have the pleasure of inviting you to report on the 3rd International Conference on innovative approaches In Head and Neck Oncology.
With major emphasis on multidisciplinarity and innovation, this meeting will specifically cover the main following topics:
More information on the conference: http://www.estro-events.org/Pages/ichno2011.aspx
More information on Head & Neck cancers on the Radiotherapy Information Centre: http://www.estro-ric.org/media/Pages/HeadandNeckCancer.aspx#Head%20&%20Neck%20cancers
Tremendous achievements in Head & Neck cancers
Head and neck cancers together make up 5% of all cancers diagnosed each year 120,000(1) across Europe. The most common head and neck cancers are:
Oral cancers represent 3% of new cases in the UK and 6% in France; while in Sri Lanka, India, Pakistan and Bangladesh, oral cancer is the most common cancer in men and may account for up to 30% of all new cases of cancer (2).
But over the last decade, tremendous achievements have been made in the management of patients with Head & Neck Cancer. Advancements in the understanding of the pathogenesis of Head & Neck malignancies could rapidly lead to the elaboration of tailored treatments:
And this is just the beginning, with many more challenges ahead of us.
(1,2) Source: European Society for Therapeutic Radiology and Oncology (ESTRO) 2008, www.estro-ric.org
You can pre-register now by writing to email@example.com. On-site registration is possible at the Press Registration Desk. You will be asked for your press card and a letter of assignment.
|Contact: Cecile Hardon-Villard|
European Society for Medical Oncology